Ladarixin With Sotorasib in Advanced NSCLC - Phase II

Clinical trial NCT05815186 · WITHDRAWN

Trial details

NCT number: NCT05815186
Sponsor: NYU Langone Health
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

Start date: 2024-04-01
Primary completion: 2025-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.